Antonio Martellini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Antonio Martellini has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Alessio Mattesini
Structural Interventional Cardiology Division, Cardio-Toraco-Vascular Department, Careggi University Hospital, Largo Brambilla 3, 50141 Florence, Italy
2 shared publicationsCarlo Di Mario
Structural Interventional Cardiology Division, Cardio-Toraco-Vascular Department, Careggi University Hospital, Largo Brambilla 3, 50141 Florence, Italy
2 shared publications- Carlo Di Mario
Structural Interventional Cardiology, Department of Clinical and Experimental Medicine, Careggi University Hospital, Florence, Italy
1 shared publication Carlo Trani
Dipartimento di Scienze Cardiovascolari e Toraciche, Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy, Italian IRCCS Cardiovascular Network and Università Cattolica del Sacro Cuore, Rome, Italy
1 shared publicationCarlo di Mario
Structural Interventional Cardiology, University Hospital Careggi, Florence, Italy
1 shared publicationCarlotta Sorini Dini
Spedali Riuniti, Leghorn, Italy
1 shared publication
Latest Publications
- Open Access
- 21 August 2020
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 4 (5) , 1-2
Percutaneous Watchman FLX implantation in a patient with previous mitral valve surgery and large-sized left atrial appendage
Percutaneous left atrial appendage (LAA) occlusion in patients with history of mitral valve surgery represent a challenge for interventional cardiologists, due to large-sized LAA and to the presence of prosthetic material. Patients with previous mitral valve surgery represent a scant population among the patients treated with percutaneous LAA occlusion and there is no evidence to date to support the use of a specific device in this particular clinical setting.
- 21 August 2020
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 4 (5) , 1-2
Open AccessPercutaneous Watchman FLX implantation in a patient with previous mitral valve surgery and large-sized left atrial appendage
Percutaneous left atrial appendage (LAA) occlusion in patients with history of mitral valve surgery represent a challenge for interventional cardiologists, due to large-sized LAA and to the presence of prosthetic material. Patients with previous mitral valve surgery represent a scant population among the patients treated with percutaneous LAA occlusion and there is no evidence to date to support the use of a specific device in this particular clinical setting.
- Open Access
- 9 August 2020
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 16 (2) , 463-470
Blood lactate predicts survival after percutaneous implantation of extracorporeal life support for refractory cardiac arrest or cardiogenic shock complicating acute coronary syndrome: insights from the CareGem registry
Refractory cardiogenic shock (RCS) or refractory cardiac arrest (RCA) complicating acute coronary syndrome (ACS) is associated with extremely high mortality rate. Veno-arterial extracorporeal life support (VA-ECLS) represents a valuable therapeutic option to stabilize patients’ condition before or at the time of emergency revascularization. We analyzed 29 consecutive patients with RCS or RCA complicating ACS, and implanted with VA-ECLS in two centers who have adopted a similar, structured approach to ECLS implantation. Data were collected from January 2010 to December 2015 and ECLS had to be percutaneously implanted either before (within 48 h) or at the time of attempted percutaneous coronary revascularization (PCI). We investigated in-hospital outcome and factors associated with survival. Twenty-one (72%) were implanted for RCA, whereas 8 (28%) were implanted on ECLS for RCS. All RCA were witnessed and no-flow time was shorter than 5 min in all cases but one. All patients underwent attempted emergency PCI, using radial access in ten cases (34.5%), whereas in three patients a subsequent CABG was performed. Overall, ten patients (34.5%) survived, nine of them with a good neurological outcome. Life threatening complications, including stroke (4 pts), leg ischemia (4 pts), intestinal ischemia (5 pts), and deep vein thrombosis 2 pts), occurred frequently, but were not associated with in-hospital death. Main cause of death was multi-organ failure. PCI variables did not predict survival. Survivors were younger, with shorter low-flow time, and with ECLS mainly implanted for RCS. At multivariate analysis, levels of lactate at ECLS implantation (OR 4.32, 95%CI 1.01–18.51, p = 0.049) emerged as the only variable that independently predicted survival. In patients with RCA or RCS complicating ACS who are percutaneously implanted with ECLS before or at the time of coronary revascularization, in hospital survival rate is higher than 30%. Level of lactate at ECLS implantation appears to be the most important factor to predict survival.
- 9 August 2020
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 16 (2) , 463-470
Open AccessBlood lactate predicts survival after percutaneous implantation of extracorporeal life support for refractory cardiac arrest or cardiogenic shock complicating acute coronary syndrome: insights from the CareGem registry
Refractory cardiogenic shock (RCS) or refractory cardiac arrest (RCA) complicating acute coronary syndrome (ACS) is associated with extremely high mortality rate. Veno-arterial extracorporeal life support (VA-ECLS) represents a valuable therapeutic option to stabilize patients’ condition before or at the time of emergency revascularization. We analyzed 29 consecutive patients with RCS or RCA complicating ACS, and implanted with VA-ECLS in two centers who have adopted a similar, structured approach to ECLS implantation. Data were collected from January 2010 to December 2015 and ECLS had to be percutaneously implanted either before (within 48 h) or at the time of attempted percutaneous coronary revascularization (PCI). We investigated in-hospital outcome and factors associated with survival. Twenty-one (72%) were implanted for RCA, whereas 8 (28%) were implanted on ECLS for RCS. All RCA were witnessed and no-flow time was shorter than 5 min in all cases but one. All patients underwent attempted emergency PCI, using radial access in ten cases (34.5%), whereas in three patients a subsequent CABG was performed. Overall, ten patients (34.5%) survived, nine of them with a good neurological outcome. Life threatening complications, including stroke (4 pts), leg ischemia (4 pts), intestinal ischemia (5 pts), and deep vein thrombosis 2 pts), occurred frequently, but were not associated with in-hospital death. Main cause of death was multi-organ failure. PCI variables did not predict survival. Survivors were younger, with shorter low-flow time, and with ECLS mainly implanted for RCS. At multivariate analysis, levels of lactate at ECLS implantation (OR 4.32, 95%CI 1.01–18.51, p = 0.049) emerged as the only variable that independently predicted survival. In patients with RCA or RCS complicating ACS who are percutaneously implanted with ECLS before or at the time of coronary revascularization, in hospital survival rate is higher than 30%. Level of lactate at ECLS implantation appears to be the most important factor to predict survival.
- Open Access
- 21 January 2019
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 40 (4) , 328-329
News from TCT San Diego 2018: Intracoronary Imaging
Over the past years, intracoronary imaging techniques have progressively evolved and growing evidence from observational studies, randomized controlled trials (RCTs) and meta-analyses support their use in order to achieve better procedural results and to improve clinical outcomes. The results of two important trials have been recently presented, adding strong evidence concerning the use of intravascular ultrasound (IVUS) guidance during drug-eluting stent (DES) implantation (ULTIMATE trial), and the role of near-infrared spectroscopy (NIRS) imaging as a tool to identify both patients and coronary plaques at high risk for future events (LIPID RICH PLAQUE study).
- 21 January 2019
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 40 (4) , 328-329
Open AccessNews from TCT San Diego 2018: Intracoronary Imaging
Over the past years, intracoronary imaging techniques have progressively evolved and growing evidence from observational studies, randomized controlled trials (RCTs) and meta-analyses support their use in order to achieve better procedural results and to improve clinical outcomes. The results of two important trials have been recently presented, adding strong evidence concerning the use of intravascular ultrasound (IVUS) guidance during drug-eluting stent (DES) implantation (ULTIMATE trial), and the role of near-infrared spectroscopy (NIRS) imaging as a tool to identify both patients and coronary plaques at high risk for future events (LIPID RICH PLAQUE study).
- 1 January 2019
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 14 (3) , 341-343
High-sensitivity troponin allows accurate rapid diagnosis and discharge but it is not a substitute for a comprehensive patient evaluation
- 1 January 2019
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 14 (3) , 341-343
High-sensitivity troponin allows accurate rapid diagnosis and discharge but it is not a substitute for a comprehensive patient evaluation